Dr. Reddy's Laboratories Ltd.
7-1-27 Greenlands
Ameerpet
Hyderabad,
500016
India - Map
Phone: 91 40 2373 1946
Fax: 91 40 2373 1955
Web Site: http://www.drreddys.com
| Dr. Reddys Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec International for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. K. Anji Reddy Ph.D., 69
Co-Founder, Exec. Chairman and Member of Scientific Advisory Board |
$
106.00K | N/A | Mr. G. V. Prasad B. Sc.(Chem Eng.), M.S. (Indl. Admn.), 48
Exec. Vice Chairman, Chief Exec. Officer, Member of The Management Council, Chairman of Investment Committee, Member of Management Committee and Member of Strategy Committee |
$
85.00K | N/A | Mr. Vishar Subramanian Vasudevan B.Com., ACA, 58
Pres, Member of the Management Council, Pres of Eurpoean Generics Bus. and Head of Europe Generics |
N/A
| N/A | Mr. Umang Vohra , 37
Chief Financial Officer, Sr. VP and Member of Management Council |
$
0 | N/A | Mr. Saumen Chakraborty , 48
Pres of Corp. & Global Generics Operations and Member of the Management Council |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.14%
Profile
